New Born Screening Market Expert Insights with Key Market Players, Market Dynamics and Market Analysis 2027 | Coherent Market Insights

Global Newborn Screening Market

The Global Newborn Screening Market, by Product Type (Pulse Oximetry, Mass Spectrometer, Assay Kits, and Hearing Screening Devices), by Application (Thyroid Disorder, Hearing Disability, Blood Spot Disease, Sickle Cell Disease, Maple Syrup Urine Disease, and Critical Congenital Cardiac Disease), by Test (Urine Test, Hearing Test, Blood Test, and Cardiac Test), and by Region (North America, Asia Pacific, Latin America, Europe, Middle East, and Africa) had a market valuation of US$ 561.5 million in 2018, and is estimated to grow at a CAGR of 12.4 percent during the forecast period (2018 – 2026).

Infants are screened for developmental, metabolic, and genetic problems using newborn screening tests. It enables actions to be done prior to the onset of symptoms. Despite the fact that the bulk of these disorders are extremely rare, they may be cured if detected early. Over 30 diseases and illnesses are included in prenatal testing. The growing awareness of illness screening among parents is a significant element driving the growth of the newborn screening market. Furthermore, a number of government and non-government groups are working hard to improve foetal and maternal care.

Request a sample copy of report here

In June 2018, the American Society of Hematology (ASH) launched a campaign in Africa to combat sickle cell disease, urging governments, particularly in Sub-Saharan Africa, to engage in sickle cell disease newborn screening. Various illnesses are projected to be evaluated as possible candidates for inclusion in New Born Screening (NBS) programs as a result of new therapies, biomarkers, and technology. Novel therapies including hematopoietic stem cell transplantation (HSCT), enzyme replacement therapy (ERT), gene therapy, and new pharmacological medicines have enabled autoimmune illnesses to be regarded as possible candidates for NBS programs.

Browse 22 Market Data Tables and 26 Figures spread through 167 Pages and in-depth TOC on “Global Newborn Screening Market, by Product Type (Pulse Oximetry, Mass Spectrometer, Assay Kits, and Hearing Screening Devices), by Application (Thyroid Disorder, Hearing Disability, Blood Spot Disease, Sickle Cell Disease, Maple Syrup Urine Disease, and Critical Congenital Cardiac Disease), by Test (Urine Test, Hearing Test, Blood Test, and Cardiac Test), and by Region (North America, Asia Pacific, Latin America, Europe, Middle East, and Africa) – Global Forecast to 2026”

New test kits and equipment are being developed by manufacturers in the global newborn screening market in order to identify more illnesses and abnormalities at birth. Sema4 Natalis, a supplementary newborn screening test aimed to identify 193 childhood-onset illnesses or disorders, was released in February 2018 by Sema4, a health information firm that offers sophisticated genetic testing. Numerous countries are assisting firms in the development of new screening tests by easing production and trading rules. The Seeker System was authorized by the US FDA in February 2017 for the screening of four rare Lysosomal Storage Disorders (LSDs) in neonates. Fabry, Gaucher, Mucopolysaccharidosis Type I (MPS I), and Pompe disease are all detected by the Seeker system.

Key Takeaways

Due to increased government funding for newborn screening, the global newborn screening market is anticipated to grow at a CAGR of 12.4 percent over the forecast period (2018-2026). NBS programs in the U.S. test about four million babies per year, as per the National Institute of Health. This public health initiative diagnoses treatable diseases in infants, enabling therapy to commence before symptoms or long-term consequences arise.

Due to the rising number of blood tests and blood samples preserved for future use, the assay kits sector is anticipated to have the highest revenue share among product types in 2018.

Key companies contributing in the global newborn screening market are GE Life Sciences, Bio-Rad Laboratories, AB SCIEX, Agilent Technologies, ZenTech S.A., PerkinElmer Inc., Natus Medical Inc., Covidien PLC, and Masimo Corporation.

Buy-Now this research report ( Flat USD 2000 OFF ) : https://www.coherentmarketinsights.com/promo/buynow/2192

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com
U.S. Office:
Name:  Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US :  +1-206-701-6702
UK :  +44-020-8133-4027
JAPAN :  +050-5539-1737